Breathometer

The Breathometer was a device designed to measure blood alcohol content (BAC) from a breath sample. It was introduced to the market with the promise of providing an easy and accessible way for individuals to assess their own levels of intoxication and make informed decisions about their ability to drive or engage in other activities that could be dangerous under the influence of alcohol. The device connected to a smartphone via the headphone jack or Bluetooth and used a companion mobile app to display the BAC results.
The concept of the Breathometer gained significant public attention when its founder, Charles Michael Yim, appeared on the American television show Shark Tank in 2013. Yim successfully secured investment from all five "sharks," marking a notable moment in the show's history. This investment and the subsequent media exposure led to a surge in interest and sales for the Breathometer.
However, the Breathometer faced significant challenges and controversies. The Federal Trade Commission (FTC) later charged the company with false advertising, stating that the device's accuracy was not scientifically proven and that it could potentially give users a false sense of security about their ability to drive after drinking. In 2017, the company settled with the FTC, agreeing to refund customers and cease making claims about the device's accuracy without scientific evidence.
The Breathometer case serves as a cautionary tale about the importance of rigorous product testing and validation, especially for products that have significant safety implications. It also highlights the potential pitfalls of rapid product development and scaling in response to media exposure and consumer demand without adequate underlying scientific validation.
Ad. Transform your life with W8MD's Budget GLP-1 injections from $49.99


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $49.99 for the starting dose of Semaglutide and $65.00 for Tirzepatide.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
